Meet 92-Year-Old Who Heads To Office Daily, Owns 71 Hospitals And 5,000 Pharmacy Outlets—Know His Jaw-Dropping Net Worth
photoDetails english 2899820 https://zeenews.india.com/photos/business/meet-92-year-old-who-heads-to-office-daily-owns-71-hospitals-and-5000-pharmacy-outlets-know-his-jaw-dropping-net-worth-2899840 Updated:May 12, 2025, 09:48 AM IST Goes to Work Daily
1 / 8
At 92, when most people have retired from active life, Dr. Prathap C. Reddy continues to lead by example. The founder of Apollo Hospitals starts his workday at 10 a.m. and clocks out by 5 p.m., working six days a week with the discipline and energy of someone decades younger. His unwavering dedication to healthcare and service has made him a symbol of perseverance and purpose. The Visionary Behind Apollo Hospitals
2 / 8
Dr. Reddy is the visionary founder of Apollo Hospitals, India's first corporate hospital. His pioneering idea revolutionized the country's healthcare system by making high-quality medical care accessible to millions. He saw a future where Indians didn't need to travel abroad for treatment—and turned that vision into a powerful reality. Humble Beginnings
3 / 8
Born in Chennai, Dr. Reddy completed his MBBS from Stanley Medical College before moving to the United States to train as a cardiologist. While he had the opportunity to build a successful career overseas, a heartfelt letter from his father in the early 1970s urged him to return home and contribute to his country. That decision would go on to change Indian healthcare forever. A Personal Tragedy
4 / 8
In 1979, a patient tragically died in India due to the lack of advanced medical facilities—a moment that deeply impacted Dr. Reddy. This event became the turning point that pushed him to establish Apollo Hospitals. He vowed to bring world-class healthcare to India, so that no life would be lost due to inadequate infrastructure ever again. From One Hospital to Healthcare Empire
5 / 8
What started as a single hospital has today grown into a healthcare empire. Apollo Hospitals now operates 71 hospitals, over 5,000 pharmacy outlets, 291 primary care clinics, a diagnostic network, and a digital health platform. The group has become a household name in India, offering care across specialties and cities, and continues to expand its reach. Massive Market Cap and Family Control
6 / 8
Apollo Hospitals is not just a leader in healthcare, it's a financial giant too. The company boasts a market capitalization of over Rs 70,000 crore. The Reddy family holds a 29.3 per cent stake in the group, reflecting their deep involvement and long-term commitment to the organization's mission and success. Net Worth
7 / 8
According to Forbes, Dr. Prathap C. Reddy's net worth is estimated at Rs 26,560 crore. Despite his massive financial success, he remains grounded and focused on service. His wealth is a byproduct of his purpose—to build a healthier India—rather than a personal goal. A Life That Inspires Generations
8 / 8
Dr. Reddy's life story is a blend of ambition, empathy, and action. In an interview with Business Today, he once said, 'Success should make us humble and inspire us to do more for the country.' Even at 92, he embodies this principle daily. His journey serves as a powerful reminder that age is no barrier to leadership, and that true success lies in creating lasting impact.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
32 minutes ago
- Time of India
Singapore SCID case: Indian-origin baby beats rare disorder; Stem-cell transplant saves life
Representative photo A 19-month-old Indian-origin boy in Singapore has made a remarkable recovery from a rare and life-threatening genetic disorder, thanks to a timely stem-cell transplant , according to a report by The Straits Times. Mannat Singh was just six days old when doctors diagnosed him with severe combined immunodeficiency (SCID), a condition that left him dangerously vulnerable—even to something as common as the flu. Born in Singapore, Mannat holds the distinction of being the first baby in the country to be diagnosed with SCID at birth. He underwent a successful stem-cell transplant in 2023, a crucial step that came before the onset of symptoms. Today, Mannat is thriving, the newspaper reported. His specific condition, known as Artemis SCID , is an extremely rare and recessive form of radiosensitive SCID. This meant certain treatments like radiation and specific scans were off-limits. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo Without intervention, Mannat would not have survived beyond his first birthday, the report said. His mother, Harminder Kaur, a 39-year-old nurse, spoke about the emotional weight she carried after learning about her son's condition. 'Because I made him this way,' she said, recalling her initial feelings of guilt and fear. His father, Harminder Singh, also 39 and an IT consultant, admitted the prognosis was hard to accept. 'It did not help our state of mind when his odds were stacked against him,' he said. Now, with Mannat healthy and growing, Kaur said, 'I feel now that life has returned to normal and we have put the past behind us.' The diagnosis was made at KK Women's and Children's Hospital (KKH) through the National Expanded Newborn Screening (NENS) programme. Launched in 2006, NENS initially aimed to screen all newborns in Singapore for metabolic and heritable diseases. In 2019, the programme broadened its scope to include five additional treatable childhood-onset conditions , including SCID and cystic fibrosis. Dr Bianca Chan, a consultant in the rheumatology and immunology service at KKH, emphasized the importance of early detection. 'The highest success is when it is performed within the first three to four months of life, before the baby develops significant infections. This makes SCID screening at birth crucial for early diagnosis to actively prevent infection,' Dr Chan said. She added that the only real cure for SCID is a bone marrow transplant from a healthy donor. Stem cells from the donor's bone marrow can develop into the T-cells that SCID babies critically lack, allowing them to build a functioning immune system. (With PTI inputs)
Hindustan Times
33 minutes ago
- Hindustan Times
Dermat shares 'skin cycling' may be the secret to unlock glowing skin for Indians, suggests beginner-friendly routine
Skincare is slowly reaching a saturation point with the excessive layering and the increasing steps in your routine. Even your skin has hit the threshold of tolerance. This results in unexpected breakouts and irritated skin, leaving many confused, despite doing everything 'right.' But the key to healthy skin is simplicity. The skincare landscape in India now is seeing a growing consciousness towards skin cycling, which is rooted in the philosophy of minimalism and the idea of recovery. In an interview with HT Lifestyle, Dr Prashant Agrawal, Sr. Dermatologist, Formulator and Hair Transplant Surgeon, explained how skin cycling helps in the much-needed skin recovery, reducing flare-ups. He said,"Indians are gradually moving away from complicated, multi-step routines toward a more mindful approach. One of the most noteworthy trends leading this shift is skin cycling. As a practising dermatologist, I've witnessed a sharp rise in issues related to over-exfoliation, barrier disruption, and ingredient overload. Overdoing actives like daily acids, retinoids, and heavy layering is leaving many with reactive skin with frequent flare-ups. These aren't signs of 'bad skin' or 'bad products,' but rather signs of overuse and lack of recovery time. As a result, skinimalism, using fewer, smarter products, is gaining traction, with skin cycling leading the charge. The shift includes using only what skin needs, protecting the barrier, and understanding actives wisely." Dr Prashant Agrawal shared a detailed guide on skin cycling, why Indians need it more right now, bursting common myths and an easy beginner-friendly routine: Skin cycling is a methodical skincare approach that alternates active ingredient use with rest days to support the skin's natural repair processes. A typical 4-day cycle includes: This structured rotation helps the skin reap the benefits of active ingredients without triggering irritation, inflammation, or sensitivity that can come from daily use. ALSO READ: Complete guide to retinoids: When to start and introduce it in your skincare routine, based on skin type With time and consistent care, actives like antioxidants, peptides, or stronger exfoliants can be introduced based on specific skin goals. Truth: It's a proactive approach suitable for anyone looking to build a sustainable, effective skincare routine. Truth: Many people notice improvements in skin texture, reduced breakouts, and enhanced radiance within just 2–3 weeks. Truth: You don't have to eliminate them, just time them wisely. For instance, vitamin C in the morning can coexist with skin cycling at night, as long as it's not combined with strong nighttime actives. ALSO READ: Hot water baths to popping pimples: Dermatologist reveals biggest skincare mistakes you might be making Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Mint
34 minutes ago
- Mint
AI-native startups edge out SaaS in investor playbooks as tech shift accelerates
India's venture capital ecosystem is undergoing a pivotal shift in 2025, with investors increasingly backing artificial intelligence (AI)-native startups over traditional software-as-a-service (SaaS) players. Between January and 4 June, AI-focused startups raised $454 million across 65 deals, slightly surpassing SaaS firms, which drew $432 million over 52 deals, according to data from Venture Intelligence. While some overlap exists as SaaS companies adopt AI features, the trend points to a deeper reset in investor priorities. 'AI-led startups are commanding 3–4x valuation premiums over traditional SaaS businesses, thanks to their potential for faster scalability and deeper, more transformative use cases," said Abhinav Chaturvedi, partner at Accel. Also read: 10 Indian AI startups and products to watch out for Blurring boundaries However, to stay competitive with pure-play AI startups, many SaaS companies are now streamlining operations and aggressively investing in artificial intelligence, according to multiple industry executives. This trend is pushing established SaaS companies to retool quickly. 'If SaaS companies don't integrate AI, they are unlikely to survive the next 2–3 years," said Nitin Bhatia, managing director at DC Advisory. 'We're seeing the switch happen where pure-play SaaS startups don't exist anymore. AI is becoming a fundamental part of what they offer—whether it's to enhance customer experience or product capabilities." This transition is also shaping the investment strategies of venture capital firms such as Stellaris Venture Partners, Bessemer Venture Partners, and Accel, who see the convergence of AI and SaaS playing out across their portfolios. Accel's Chaturvedi pointed to SaaS portfolio companies like Chargebee, which is exploring newer monetisation models like usage-based pricing, and BrowserStack and Testsigma, which are embedding AI to automate testing—showing how legacy players are not just adapting but helping shape this transformation. Some of the largest AI-linked fundraises this year include Netradyne's $90 million, SpotDraft's $54 million, and Infinite Uptime's $35 million rounds, according to Venture Intelligence data. The narrowing gap between AI and SaaS deal volumes underscores growing investor appetite for pure-play AI models. Deal data reflects this shift: in 2024, there were 193 SaaS deals versus 145 AI deals. A year earlier, SaaS saw 159 deals compared to just 96 in AI. While SaaS still leads in terms of overall capital raised, AI startups are quickly gaining ground with more focused, domain-specific solutions. Also read: Meta in talks to invest nearly $10 billion in artificial intelligence startup Scale AI Even within traditional SaaS portfolios, companies are recalibrating. 'Our existing SaaS portfolio companies are investing aggressively in AI capabilities. From Whatfix in the digital adoption space to Factors in marketing automation, most of our portfolio companies are already using AI to add features, increase convenience and reduce cost for their customers," said Ritesh Banglani, founding partner at Stellaris Venture Partners. According to Banglani, more than 80% of Stellaris' B2B SaaS deal flow is now led by AI-centric solutions. 'This shift will transform every process within an enterprise from marketing and sales to accounting and finance," he added. A generational shift Industry veterans believe the shift marks a generational reset for Indian software startups. SaaS inflows have dried up, Zoho founder Sridhar Vembu said last week, attributing it to rising investor appetite for AI and growing profitability pressure on SaaS firms. He noted that artificial intelligence is now superseding traditional SaaS models in funding priority. Still, the broader outlook for SaaS remains strong—with a caveat. In August, Bessemer Venture Partners projected that the Indian SaaS market could generate three times more revenue by 2030 compared to today, driven in large part by the infusion of AI. In 2025, Indian SaaS is expected to clock $25 billion in annual recurring revenue. Bessemer also expects India to see a similar shift as the global SaaS wave of the late 2010s—with AI software exports playing a bigger role in the $400 billion global services market. As the Indian startup ecosystem matures, the once-clear boundaries between SaaS and AI are dissolving—with capital, innovation and talent increasingly flowing toward platforms that can do both. Also read: Boom in AI fuels a flurry of startups
